- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03934944
A Feasibility Study Comparing Usual Foot Education and Phone App Alerts in Patients With Increased Risk of Diabetic Foot
A Feasibility Study to Compare Usual Methods of Patient Education With a Multi-media Presentation and Weekly 'Foot-alerts' Using 21st Century Technologies to Improve Patient Diabetic Foot Care Knowledge and Practices
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is recommended that patients who are at moderate or high risk of diabetic foot ulcer (DFU) are seen by a healthcare professional for foot review every 2-6 months. Yet, diabetic foot ulcers remain the leading cause of non-traumatic lower limb amputation with an amputation occurring every 20 secs. This suggests that additional information and prompts, as well as regular follow-up, are required. Additionally, long term diabetic foot complications including loss of protective pain sensation are related to poor glycaemic control.
This single blinded randomised study aims to determine if weekly foot alerts (a total of 12 alerts cycled over 12-months), delivered by the MyU phone application in combination with usual education routes and follow-up, improves patient foot care behaviour and foot care knowledge. Using standardized questionnaires at baseline and 12-months. Furthermore, does the frequency of viewing/engaging in foot alert content influence foot care knowledge and behaviour.
Secondary objectives are to determine: 1) if individuals who receive 7-foot review appointments in a 12-month period have better foot care knowledge and behaviour when compared to those seen less frequently regardless of educational route. 2) Baseline and 12-months HbA1c blood test will be measured to establish if any changes occurred between the two groups.
Expected results: The investigators hypothesized that participants randomised to the intervention group (Phone app) will have improved foot care knowledge and foot health behaviours.
Sample size: 100 patients with a 1:1 ratio
Quality Assurance:
A standard operating procedure based on established diabetic foot screening tools will be used to ensure the inter-rater reliability of foot assessment.
Educational material will go through back translation to ensure the accuracy of the content. Feedback on content, meaning and usability of the English and Arabic documents from a sample of 10 participants will be sought.
To maintain investigator blinding the participants will be escorted to the video viewing room by a research coordinator.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kay Scarsbrook Khan, BSc
- Phone Number: 6815 +965 22242999
- Email: kay.khan@dasmaninstitute.org
Study Locations
-
-
-
Kuwait, Kuwait
- Recruiting
- Dasman Diabetes Institute
-
Contact:
- Kay Scarsbrook Khan, BSc
- Phone Number: 6815 +96522242999
- Email: kay.khan@dasmaninstitute.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female 21 yrs or
- Type 2 Diabetes Mellitus or Type 1 Diabetes Mellitus greater than 5-yrs
- At least one diabetic foot risk factor (i.e Loss of Pain Sensation Peripheral Arterial Disease etc)
- Ability to understand Arabic or English to a skill listening level 3 and speaking level +2 (Interagency Language Roundtable).
- Own a smartphone and access to the internet
- The ability to understand the study procedures and to comply with them for the entire length of the study
- Resident in Kuwait
Exclusion Criteria:
- Chronic kidney disease stage 3 or above
- Cognitive impairment
- Acute psychiatric illness
- Hearing or visual impairment that would mean the intervention would not be understood
- phone application inaccessible for more than 4 continuous weeks
- Refusal to give written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Phone application arm
Participants will have access to a educational video and foot alerts at weekly intervals to supplement usual Podiatry care and education.
|
Weekly foot alerts and educational video
Other Names:
|
Other: Usual care
Participants will have Podiatry care and education.
|
Usual routine of diabetic foot education
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in foot care knowledge as measured by the adapted foot care knowledge test
Time Frame: 12 months
|
Change in the adapted Diabetic Foot Care Knowledge test (Pollock et al. 2004 and Rheeder et al. 2008) score between baseline and 12-months in the two groups This 12-question test has a maximum score of 12, and a minimum score of 0. Each correct answer is given one point, where a low score denotes low knowledge and high score denotes high knowledge.
For each group a mean will be calculated and significance of differences will be tested using the students two tailed unpaired T-Test.
|
12 months
|
Change in foot care behaviour as measured by the SDSCA
Time Frame: 12 months
|
SDCS questionnaire includes a number of domains which evaluate different aspects of patient behaviour performed during the previous week. Each domain has one or more questions that are marked between 0-7. The domains are:
These measures allow formulation of a composite reflection in changes in the patient's behaviour between baseline and 12-months in the two groups. Differences will be tested using the students two-tailed unpaired T-Test. |
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HbA1c from baseline
Time Frame: 12 months
|
Change in HbA1c measurement taken from venous blood supply at baseline and 12-months between intervention and control group.
|
12 months
|
Proportion of participants who developed a new diabetic foot ulcer
Time Frame: 12 months
|
Case report form.
Diabetic foot ulcer is defined as a wound below the ankle in someone with diabetes and will be classified using the University of Texas Wound classification System.
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kay Scarsbrook Khan, BSc, Dasman Diabetes Institute
- Principal Investigator: Ebaa Al Ozairi, MD, Dasman Diabetes Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RA HM-2018_044
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Foot
-
Johns Hopkins UniversityWithdrawnDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Mixed | Vascular Ulcer (Arterial or Venous Including Diabetic Ulcers Not Located on the Foot)
-
University of PadovaUnknownDiabetic Foot | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Deformities FootItaly
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
Exciton Technologies Inc.CompletedDiabetic Foot Ulcer | Diabetic Foot Infection | Non-healing Diabetic Foot UlcerCanada
-
Integra LifeSciences CorporationMayo Clinic; Temple University; Samuel Merritt University; New York College of... and other collaboratorsCompletedFoot Ulcers, DiabeticUnited States
-
University of the PunjabHigher Education Commission (Pakistan); Centre of Excellence in Molecular Biology... and other collaboratorsRecruitingDiabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | Chronic Diabetic Ulcer of Left Foot | Chronic Diabetic Foot...Pakistan
-
Corporacion Parc TauliCompletedDiabetic Foot Ulcer | Diabetic Foot Ulcer NeuropathicPakistan
-
University of MinnesotaRecruitingDiabetes Mellitus | Foot Ulcer | Ulcer | Diabetic Foot Ulcer | Foot Ulcer, Diabetic | Ulcer Foot | Ulcer, Leg | Ankle UlcerUnited States
-
HealthpointCompletedDiabetic Foot Ulcers | Diabetic Foot WoundsUnited States, Canada
-
HealthpointCompleted
Clinical Trials on Phone application
-
Mayo ClinicArizona State UniversityCompleted
-
University Hospitals Cleveland Medical CenterCompleted
-
Asthma Research Group Windsor-Essex IncUniversity Health Network, TorontoActive, not recruiting
-
Sonova AGWithdrawn
-
Yeditepe UniversityUnknownFoot Diseases | Plantar Fascitis | Achilles Tendinopathy | Feet Pes Planus (Flatfoot) | Feet Pes CavusTurkey
-
Instituto Cardiovascular de Buenos AiresUnknown
-
Karolinska InstitutetCompletedFlexor Digitorum Profundus InjurySweden
-
Natalie GarrattInnovate UK; Gendius LtdCompleted
-
University of HaifaSheba Medical Center; Ben-Gurion University of the NegevNot yet recruitingVestibular Diseases | Vestibular Disorder | Vestibular AbnormalityIsrael
-
MelanomaPRO, RussiaPrivolzhsky Research Medical UniversityRecruitingNevus | Nevus, Pigmented | Melanoma (Skin) | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowen's Disease | Nevus, Spitz | Melanoma in Situ | Nevus Halo | Spot PigmentedRussian Federation